Company / Current Liabilities
Century Therapeutics, Inc. Current Liabilities History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$20.2M
FY2025
5-year range
$17.8M / $129.8M
FY2022-FY2025
Trend
-84.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $18M to $20M over the past 2 years.
Based on SEC 10-K filings.
$20M in FY2025 with a 3-year CAGR of -12.1%.
Increased from $18M to $20M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -12.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -12.1%, indicating a declining trend.
- In FY2025, current liabilities decreased 84.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.2M | -84.4% |
| FY2024 | $129.8M | +627.2% |
| FY2023 | $17.8M | -40.1% |
| FY2022 | $29.8M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026